Press Release ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) 2 hours ago
Press Release ORICĀ® Pharmaceuticals Reports Second Quarter 2026 Financial Results and Operational Updates Aug 3
Press Release ORICĀ® Pharmaceuticals Announces Three Presentations at the European Society for Medical Oncology (ESMO) Congress 2026 Jul 20